Cryofibrinogenemia: New Insights into Clinical and Pathogenic Features

American Journal of Medicine

Volumn 122, Issue 12, 2009, Pages 1128-1135

  Saadoun, David ^a   Elalamy, Ismail ^b   Ghillani Dalbin, Pascale ^c   Sene, Damien ^a   Delluc, Aurelien ^a   Cacoub, Patrice ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b HÔPITAL TENON   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Cryofibrinogenemia; Cryoproteins; Fibrinolysis; Vasculitis

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA 2 MACROGLOBULIN; ALTEPLASE; ANTICOAGULANT AGENT; ANTIVITAMIN K; AZATHIOPRINE; CRYOFIBRINOGEN; CRYOGLOBULIN; CYCLOPHOSPHAMIDE; GLOBULIN; IMMUNOSUPPRESSIVE AGENT; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREDNISONE; STEROID; UNCLASSIFIED DRUG;

ADULT; AGED; ARTHRALGIA; ARTICLE; BLOOD CLOTTING; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CLINICAL FEATURE; COLD SENSITIVITY; CRYOFIBRINOGENEMIA; FEMALE; FIBRINOLYSIS; FIBRINOLYTIC THERAPY; GANGRENE; HUMAN; LEG AMPUTATION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PURPURA; RELAPSE; REMISSION; SEPTICEMIA; SKIN NECROSIS; SYSTEMIC DISEASE; THROMBOSIS; TREATMENT RESPONSE;

ADRENAL CORTEX HORMONES; ALPHA-MACROGLOBULINS; AMPUTATION; ARTHRALGIA; COLD TEMPERATURE; CRYOGLOBULINEMIA; CRYOGLOBULINS; FEMALE; FIBRINOLYSIS; FIBRINOLYTIC AGENTS; GANGRENE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEG; MALE; MIDDLE AGED; NECROSIS; PLASMAPHERESIS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PURPURA; RAYNAUD DISEASE; RECURRENCE; REMISSION INDUCTION; SEPSIS; SERUM GLOBULINS; SKIN; THROMBOSIS; URTICARIA;

EID: 72049095055     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2009.03.040     Document Type: Article

References (25)

1. Korst D.R., and Kratochvil C.H. Cryofibrinogen in a case of lung neoplasm associated with thrombophlebitis migrans. Blood 10 (1955) 945-953
2. Stathakis N.E., Karamanolis D., Koukoulis G., and Tsianos E. Characterization of cryofibrinogen isolated from patients plasma. Haemostasis 10 (1981) 195-202
3. Amdo T.D., and Welker J.A. An approach to the diagnosis and treatment of cryofibrinogenemia. Am J Med 116 (2004) 332-337
4. Blanco R., Martinez-Taboada V.M., Rodriguez-Valverde V., et al. Henoch-Schonlein purpura in adulthood and childhood: two different expressions of the same syndrome. Arthritis Rheum 40 (1997) 859-864
5. Glueck H.I., and Herrmann L.G. Cold-precipitable fibrinogen, "cryofibrinogen". Arch Intern Med 113 (1964) 748-757
6. Smith S.B., and Arkin C. Cryofibrinogenemia: incidence, clinical correlations, and a review of the literature. Am J Clin Pathol 58 (1972) 524-530
7. Jager B.V. Cryofibrinogenemia. N Engl J Med 266 (1962) 579-583
8. Griswold W.R., Simon G., and McIntosh R.M. Anaphylactoid purpura, cold exposure, and cryofibrinogenemia. Ann Intern Med 78 (1973) 611
9. Falanga V., Kirsner R.S., Eaglstein W.H., et al. Stanozolol in treatment of leg ulcers due to cryofibrinogenaemia. Lancet 338 (1991) 347-348
10. Copeman P.W. Cryofibrinogenaemia and skin ulcers: treatment with plasmapheresis. Br J Dermatol 101 Suppl 17 (1979) 57-58
11. Harris N.L., Jaffe E.S., Diebold J., et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 17 (1999) 3835-3849
12. Gerotziafas G.T., Depasse F., Busson J., et al. Towards a standardization of thrombin generation assessment: the influence of tissue factor, platelets and phospholipids concentration on the normal values of Thrombogram-Thrombinoscope assay. Thromb J 3 (2005) 16
13. Elalamy I., Chakroun T., Gerotziafas G.T., et al. Circulating platelet-leukocyte aggregates: a marker of microvascular injury in diabetic patients. Thromb Res 121 (2008) 843-848 Epub 2007 Sep 1
14. Nagy J., Ambrus M., Paal M., et al. Cryoglobulinaemia and cryofibrinogenaemia in IgA nephropathy: a follow-up study. Nephron 46 (1987) 337-342
15. Sawada K., Takahashi R., Saniabadi A.R., et al. Elevated plasma cryofibrinogen in patients with active inflammatory bowel disease is morbigenous. World J Gastroenterol 12 (2006) 1621-1625
16. Wulffraat N., Meyer K.J., Zegers B.J., and Kuis W. Familial presence of primary cryofibrinogenaemia, a report of three cases. Br J Rheumatol 35 (1996) 102-104
17. Euler H.H., Zeuner R.A., Beress R., et al. Monoclonal cryo-antifibrinogenemia. Arthritis Rheum 39 (1996) 1066-1069
18. Rachmilewitz E.A., Sacks M.I., and Zlotnick A. Essential cryofibrinogenemia. Clinical, pathological and immunological studies. Isr J Med Sci 6 (1970) 32-43
19. Blain H., Cacoub P., Musset L., et al. Cryofibrinogenaemia: a study of 49 patients. Clin Exp Immunol 120 (2000) 253-260
20. Kalbfleisch J.M., and Bird R.M. Cryofibrinogenemia. N Engl J Med 263 (1960) 881-886
21. Delluc A., Saadoun D., Ghillani-Dalbin P., et al. Cryofibrinogen in patients with hepatitis C virus infection. Am J Med 121 (2008) 624-631
22. Belizna C.C., Tron F., Joly P., et al. Outcome of essential cryofibrinogenaemia in a series of 61 patients. Rheumatology (Oxford) 47 (2008) 205-207
23. Saadoun D., Sellam J., Ghillani-Dalbin P., et al. Increased risks of lymphoma and death among patients with non-hepatitis C virus-related mixed cryoglobulinemia. Arch Intern Med 166 (2006) 2101-2108
24. Kirsner R.S., Eaglstein W.H., Katz M.H., et al. Stanozolol causes rapid pain relief and healing of cutaneous ulcers caused by cryofibrinogenemia. J Am Acad Dermatol 28 (1993) 71-74
25. Rubegni P., Flori M.L., Fimiani M., and Andreassi L. A case of cryofibrinogenaemia responsive to stanozolol. Br J Haematol 93 (1996) 217-219